KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Dec 04, 2024 - 1:52PM >>  ABB India 7646.8  [ 1.43% ]  ACC 2246.4  [ -1.97% ]  Ambuja Cements 562  [ -0.83% ]  Asian Paints Ltd. 2461  [ -0.32% ]  Axis Bank Ltd. 1158.1  [ -0.17% ]  Bajaj Auto 9028.05  [ -1.45% ]  Bank of Baroda 255.8  [ 0.51% ]  Bharti Airtel 1589.1  [ -1.89% ]  Bharat Heavy Ele 251  [ -0.53% ]  Bharat Petroleum 294.8  [ 0.22% ]  Britannia Ind. 4896.2  [ -0.27% ]  Cipla 1507.15  [ -1.78% ]  Coal India 419.65  [ -0.57% ]  Colgate Palm. 2858  [ -1.32% ]  Dabur India 521.2  [ -0.31% ]  DLF Ltd. 842.8  [ -0.48% ]  Dr. Reddy's Labs 1213.9  [ -0.91% ]  GAIL (India) 204.4  [ 2.20% ]  Grasim Inds. 2704.3  [ -0.36% ]  HCL Technologies 1884  [ -0.27% ]  HDFC 2729.95  [ -0.62% ]  HDFC Bank 1855  [ 1.54% ]  Hero MotoCorp 4633  [ -1.37% ]  Hindustan Unilever L 2481.5  [ 0.01% ]  Hindalco Indus. 661.25  [ -0.88% ]  ICICI Bank 1310.35  [ 0.23% ]  IDFC L 108  [ -1.77% ]  Indian Hotels Co 811.25  [ 0.61% ]  IndusInd Bank 994.2  [ -0.42% ]  Infosys L 1885  [ -0.34% ]  ITC Ltd. 471.5  [ -0.17% ]  Jindal St & Pwr 922.75  [ -0.29% ]  Kotak Mahindra Bank 1755.75  [ 0.36% ]  L&T 3787  [ 0.10% ]  Lupin Ltd. 2083.7  [ 0.11% ]  Mahi. & Mahi 3024  [ -0.07% ]  Maruti Suzuki India 11158.45  [ -1.06% ]  MTNL 49.4  [ 0.53% ]  Nestle India 2250.15  [ -0.46% ]  NIIT Ltd. 221  [ -0.50% ]  NMDC Ltd. 233.15  [ -1.02% ]  NTPC 370.95  [ 0.94% ]  ONGC 261.8  [ -0.17% ]  Punj. NationlBak 108.4  [ 0.42% ]  Power Grid Corpo 323.9  [ -1.77% ]  Reliance Inds. 1309  [ -1.08% ]  SBI 853  [ -0.11% ]  Vedanta 465.05  [ -0.70% ]  Shipping Corpn. 237.35  [ -0.15% ]  Sun Pharma. 1788.45  [ -0.56% ]  Tata Chemicals 1127  [ -0.80% ]  Tata Consumer Produc 952.9  [ -0.13% ]  Tata Motors 786.3  [ -1.85% ]  Tata Steel 144.7  [ -1.26% ]  Tata Power Co. 425.15  [ -0.85% ]  Tata Consultancy 4347.55  [ 1.07% ]  Tech Mahindra 1750  [ 0.03% ]  UltraTech Cement 11812.95  [ -0.31% ]  United Spirits 1525.7  [ -1.09% ]  Wipro 293.25  [ 0.53% ]  Zee Entertainment En 137.7  [ -0.29% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    SHARON BIO-MEDICINE LTD.

    28 March 2019 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE028B01029 BSE Code / NSE Code 532908 / SHARONBIO Book Value (Rs.) -1,025.68 Face Value 2.00
    Bookclosure 27/09/2016 52Week High 7 EPS 33.02 P/E 0.10
    Market Cap. 1.90 Cr. 52Week Low 3 P/BV / Div Yield (%) 0.00 / 0.00 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    1995: Current Mnagement took over and started manufacturing of Pharma intermediates

    1997: Started manufacturing API's - launched its first drug Trimetazidine di hydrochloride

    2000: Came withpublic offering of 25% Shares. Issue was oversubscribed by 3.85 times.

    2000: Set up a R&D block to out Process synthesis for API's & Intermediates.

    Jan 2005: Hon, Finance Minister of India Mr.P.Chidambaram put our company on the INDO NEXT at the BOMBAY STOCK EXCHANGE.

    Jan 2005: Company was awarded with the ISO 9001-2000 accreditation by BVQI - UKAS & BVQI - ANAB

    Mid 2005: Commissioning of a State of Art Formulation Unit for Oral Solid Dosages was started, Estimated cost of the project over 8 m USD

    2006: Currently one of the leading manufacturers of Trimetazidine Di HCL , Ketoconazole and Pantoprazole Sodium in the country,besides catering to a widerange of drug intermedites for the Anti fungal & Anti Ulcer categories to name a few.

    The services provided by the company are contract research and manufacturers, technology transfers and project consultancy.

    2009 

    - Company name has been changed from Sharon Pharma Chem Ltd to Sharon Bio-Medicine Ltd                                      .
    2010

    - Sharon Bio-Medicine Ltd has appointed Mr. Drunal Shah and Mr. Harish Palecanda, as Directors of the Company, w.e.f. December 31, 2009.

    2011

    - Sharon Bio-Medicine Ltd has signed Memorandum of Understanding on February 24, 2011 between Sharon Bio-Medicine Ltd. and The State - Joint Stock Concern "Uzpharmsanoat".

    - Sharon Bio-Medicine Ltd "Approval of Good Laboratory Practices by Ministry of Science & Technology, New Delhi for Toxicology Unit"

    2012

    - Sharon Bio-Medicine Ltd Board recommends Dividend dividend @ Rs. 1.80 per share subject to approval of shareholders at the Annual General Meeting.

    - Sharon Bio-Medicine Ltd receives Rs 690 lakh subsidy from Ministry of Science & Technology

    2013

    - Sharon Bio-Medicine has setting up a Genotoxicity Laboratory at Taloja near Navi Mumbai. -Sharon has recommended dividend of Rs. 1.50/- per share. - Mr. Madhav Manohar has been appointed as Additional Director w.e.f. September 01, 2013.

    2014

    -Sharon has recommended dividend @18%. -Sharon Bio-Medicine bags GLP Certificate for Raigarh unit -Sharon Bio-Medicine has announces bonus in the ratio of 1:1 -Sharon Bio-Medicine has splits its face value from Rs 10/- to 2/- 2015 -Sharon Bio-Medicine Ltd have received the certification for the approval of Good Manufacturing Practices (GMP) for both, Capsules and Tablets from United Kingdom - Medical & Health Care Product Regulatory Agency (UKMHRA) for its expanded area of Formulation and Tablets unit -Sharon Bio-Medicine gets EIR from USFDA for Dehradun mfg unit

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.